Saturday 17 October 2026
Export ARTL’s income statement to Excel — free account
Artelo Biosciences, Inc.
ARTL Healthcare Biotechnology
In the quarter to June 2026, EPS grew 94.7% and free cash flow fell 879.2%, each against the same quarter a year earlier.
2.70
0.04
−1.46%
Follow ARTL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.00 | 1.79 | 0.17 | 0.38 |
+8 more quarters Free account |
Net Debt/EBITDA |
1.69 | 3.95 | 0.22 | 0.57 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.07 | 0.40 | 0.70 | 1.12 | |
Capex/Depreciation |
0.00 | 0.00 | 2.65 | (3.01) | |
Interest Coverage |
(417.50) | (21.69) | (29.64) | (27.83) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.32 | 0.16 | 0.73 | 0.55 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(16.70) | (14.51) | (71.47) | (128.80) | |
Cash per Share |
13.93 | 125.13 | 15.75 | 59.11 | |
Shareholders Equity per Share |
16.58 | 81.27 | (33.39) | (21.75) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.58 | 81.27 | (33.39) | (21.75) | |
Free Cash Flow |
(5.03) | (1.19) | (2.72) | (3.75) | |
Working Capital |
2.92 | 4.59 | (3.35) | (3.03) | |
Capital Expenditures |
— | — | 0.19 | (0.25) | |
Net Current Asset Value |
2.91 | 4.58 | (3.38) | (3.07) | |
| Other line items | |||||
Quick Ratio |
2.89 | 1.76 | 0.15 | 0.35 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(16.70) | (14.51) | (76.40) | (120.21) | |
Capex per Share |
0.00 | 0.00 | 4.93 | (8.59) | |
Average Payables |
3.07 | 3.28 | 2.36 | 2.25 | |
Average Assets |
5.41 | 8.02 | 3.75 | 5.70 | |
Average Common Equity |
1.80 | 3.66 | 0.79 | 2.86 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 28 Sep 2026